Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefapixant in chronic cough
NCT01432730Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gefapixant in chronic cough, sponsored by Merck & Co.. Started Sep 2011; status: completed.
02
Drugs
gefapixant
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT01432730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432730.